Integrated Diagnostics Holdings plc (IDGXF)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.28 Billion EGP | -9.88% |
| 2022 | 1.29 Billion EGP | -42.6% |
| 2021 | 2.56 Billion EGP | 105.12% |
| 2020 | 1.22 Billion EGP | 28.86% |
| 2019 | 972.62 Million EGP | 20.22% |
| 2018 | 806.6 Million EGP | 29.41% |
| 2017 | 630.74 Million EGP | 42.53% |
| 2016 | 442.53 Million EGP | 39.86% |
| 2015 | 316.41 Million EGP | -13.4% |
| 2014 | 366.55 Million EGP | 25.47% |
| 2013 | 280.9 Million EGP | 46.83% |
| 2012 | 198.32 Million EGP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 668.92 Million EGP | 131.66% |
| 2024 Q2 | 357.54 Million EGP | -55.34% |
| 2023 Q3 | 353.02 Million EGP | 47.51% |
| 2023 Q4 | 281.24 Million EGP | -20.33% |
| 2023 FY | - EGP | -9.88% |
| 2023 Q1 | 360.14 Million EGP | -0.48% |
| 2023 Q2 | 239.32 Million EGP | -33.55% |
| 2022 Q2 | 291.54 Million EGP | -49.42% |
| 2022 Q1 | 576.36 Million EGP | -0.26% |
| 2022 Q4 | 361.87 Million EGP | 36.31% |
| 2022 Q3 | 265.47 Million EGP | -8.94% |
| 2022 FY | - EGP | -42.6% |
| 2021 Q3 | 812.64 Million EGP | 28.1% |
| 2021 Q4 | 577.89 Million EGP | -28.89% |
| 2021 FY | - EGP | 105.12% |
| 2021 Q2 | 634.36 Million EGP | 6.13% |
| 2021 Q1 | 597.73 Million EGP | 23.1% |
| 2020 Q4 | 485.57 Million EGP | 36.8% |
| 2020 FY | - EGP | 28.86% |
| 2020 Q3 | 354.96 Million EGP | 111.44% |
| 2020 Q2 | 167.87 Million EGP | -8.62% |
| 2020 Q1 | 183.71 Million EGP | -23.97% |
| 2019 Q2 | 202.71 Million EGP | -6.48% |
| 2019 Q1 | 216.74 Million EGP | 0.55% |
| 2019 FY | - EGP | 20.22% |
| 2019 Q4 | 241.63 Million EGP | 7.75% |
| 2019 Q3 | 224.26 Million EGP | 10.63% |
| 2018 FY | - EGP | 29.41% |
| 2018 Q2 | 162.43 Million EGP | 0.0% |
| 2018 Q4 | 215.55 Million EGP | 4.96% |
| 2018 Q1 | 162.43 Million EGP | -0.18% |
| 2018 Q3 | 205.35 Million EGP | 26.43% |
| 2017 Q2 | 126.55 Million EGP | 0.0% |
| 2017 FY | - EGP | 42.53% |
| 2017 Q1 | 126.55 Million EGP | 225.16% |
| 2017 Q3 | 182.18 Million EGP | 43.96% |
| 2017 Q4 | 162.73 Million EGP | -10.68% |
| 2016 Q2 | 122.46 Million EGP | 0.0% |
| 2016 FY | - EGP | 39.86% |
| 2016 Q4 | -101.11 Million EGP | -127.57% |
| 2016 Q3 | 366.82 Million EGP | 199.53% |
| 2016 Q1 | 122.46 Million EGP | 34.77% |
| 2015 Q2 | 112.33 Million EGP | 0.0% |
| 2015 Q1 | 112.33 Million EGP | -4.73% |
| 2015 FY | - EGP | -13.4% |
| 2015 Q4 | 90.87 Million EGP | 612.6% |
| 2015 Q3 | -17.72 Million EGP | -115.78% |
| 2014 Q4 | 117.91 Million EGP | 35.16% |
| 2014 Q3 | 87.23 Million EGP | -5.23% |
| 2014 Q2 | 92.05 Million EGP | -0.0% |
| 2014 Q1 | 92.05 Million EGP | 28.11% |
| 2014 FY | - EGP | 25.47% |
| 2013 FY | - EGP | 46.83% |
| 2013 Q2 | 69.48 Million EGP | 0.0% |
| 2013 Q3 | 69.48 Million EGP | 0.0% |
| 2013 Q4 | 71.85 Million EGP | 3.42% |
| 2013 Q1 | 69.48 Million EGP | 0.0% |
| 2012 FY | - EGP | 0.0% |
| 2012 Q4 | 69.48 Million EGP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 110184.437% |
| Arrayit Corporation | -3.07 Million USD | 41701.432% |
| Atlantic International Corp. | -5.38 Million USD | 23854.852% |
| Biocept, Inc. | -30.24 Million USD | 4333.597% |
| Bioqual, Inc. | 3.03 Million USD | -42122.317% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 169142.02% |
| DermTech, Inc. | -97.89 Million USD | 1407.838% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 56.066% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 6424.736% |
| iMD Companies, Inc. | -154.65 Thousand USD | 827909.568% |
| IDenta Corp. | 71.58 Thousand USD | -1788328.067% |
| Interpace Biosciences, Inc. | 3.83 Million USD | -33266.745% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -3308977.281% |
| InVitro International | 6680.00 USD | -19165798.204% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 23651.913% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 10551294.989% |
| Medical Imaging Corp. | -896.74 Thousand USD | 142870.384% |
| NovelStem International Corp. | -3.78 Million USD | 33918.013% |
| Optigenex Inc. | -1.18 Million USD | 107983.72% |
| PharmChem, Inc. | 1.05 Million USD | -121390.781% |
| Proteome Sciences plc | -1.13 Million USD | 112701.759% |
| Response Genetics, Inc | -19.66 Million USD | 6610.129% |
| Rennova Health, Inc. | -234.81 Thousand USD | 545330.075% |
| RushNet, Inc. | -614.85 Thousand USD | 208326.045% |
| ScreenPro Security Inc. | -3.43 Million USD | 37372.878% |
| Stella Diagnostics Inc. | -5.7 Million USD | 22531.848% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 12566.062% |
| Todos Medical Ltd. | -9.39 Million USD | 13728.72% |